(before and after)
In medical news this week, researchers at both Glasgow University and Hong Kong University have identified lower levels of Interleukin-33 (IL-33) in those with Alzheimer’s Disease (AD). These studies point to significant brain improvements when IL-33 is increased.
Although these are preliminary (but substantial) findings on mice, medical researchers anticipate protein shots for humans which would raise the levels of IL-33 in the immune system in hopes of restoring memory.
While further, rigorous study is needed about the use of IL-33 with this inflammatory disease, this appears to be exciting news! This could be a substantial development as 44 million people worldwide have AD and only 1 in 4 have been diagnosed. Read more…